|
1.
|
|
10 p, 523.7 KB |
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
/
Im, Annie (University of Pittsburgh/UPMC Hillman Cancer Center) ;
Rashidi, Armin (University of Minnesota) ;
Wang, Tao (Medical College of Wisconsin) ;
Hemmer, Michael (Medical College of Wisconsin) ;
MacMillan, Margaret L. (University of Minnesota) ;
Pidala, Joseph (H. Lee Moffitt Cancer Center and Research Institute) ;
Jagasia, Madan (Vanderbilt University Medical Center) ;
Pavletic, Steven (National Cancer Institute of Bethesda) ;
Majhail, Navneet S. (Cleveland Clinic Taussig Cancer Institute) ;
Weisdorf, Daniel (University of Minnesota) ;
Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ;
Agrawal, Vaibhav (Indiana University School of Medicine) ;
Al-Homsi, A.Samer (New York University Langone Medical Center) ;
Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ;
Askar, Medhat (Baylor University Medical Center) ;
Auletta, Jeffery J (Nationwide Children's Hospital) ;
Bashey, Asad (Blood and Marrow Transplant Program at Northside Hospital) ;
Beitinjaneh, Amer (University of Miami) ;
Bhatt, Vijaya Raj (University of Nebraska Medical Center) ;
Byrne, Michael (Vanderbilt University Medical Center) ;
Cahn, Jean-Yves (CHU Grenoble Alpes) ;
Cairo, Mitchell (New York Medical College) ;
Castillo, Paul (UF Health Shands Children's Hospital) ;
Cerny, Jan (University of Massachusetts Medical Center) ;
Chhabra, Saurabh (Medical College of Wisconsin) ;
Choe, Hannah (The Ohio State University Wexner Medical Center) ;
Ciurea, Stefan (The University of Texas MD Anderson Cancer Center) ;
Daly, Andrew (Tom Baker Cancer Center) ;
Perez, Miguel Angel Diaz (Hospital Infantil Universitario Nino Jesus) ;
Farhadfar, Nosha (University of Florida College of Medicine) ;
Gadalla, Shahinaz M. (NIH-NCI Clinical Genetics Branch) ;
Gale, Robert (Imperial College London) ;
Ganguly, Siddhartha (University of Kansas Health System) ;
Gergis, Usama (Thomas Jefferson University) ;
Hanna, Rabi (Cleveland Clinic Foundation) ;
Hematti, Peiman (University of Wisconsin) ;
Herzig, Roger (University of Kentucky Chandler Medical Center) ;
Hildebrandt, Gerhard C. (University of Kentucky) ;
Lad, Deepesh P. (Postgraduate Institute of Medical Education and Research) ;
Lee, Catherine (University of Utah) ;
Lehmann, Leslie (Dana-Farber Cancer Institute/Boston Children's Hospital) ;
Lekakis, Lazaros (University of Miami) ;
Kamble, Rammurti T. (Baylor College of Medicine) ;
Kharfan-Dabaja, Momamed A. (Mayo Clinic) ;
Khandelwal, Pooja (University of Cincinnati) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Murthy, Hemant S. (Mayo Clinic) ;
Nishihori, Taiga (Moffitt Cancer Center) ;
O'Brien, Tracey A. (Sydney Children's Hospital) ;
Olsson, Richard F. (Uppsala University) ;
Patel, Sagar S. (University of Utah) ;
Perales, Miguel-Angel (Memorial Sloan Kettering Cancer Center) ;
Prestidge, Tim (Starship Children's Hospital (Auckland, Nova Zelanda)) ;
Qayed, Muna (Emory University School of Medicine) ;
Romee, Rizwan (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ;
Schoemans, Hélène (University Hospitals Leuven (Bèlgica)) ;
Seo, Sachiko (Dokkyo Medical University) ;
Sharma, Akshay (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ;
Solh, Melhem (Northside Hospital) ;
Strair, Roger (Rutgers University) ;
Teshima, Takanori (Hokkaido University Hospital) ;
Urbano-Ispizua, Alvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Van der Poel, Marjolein (Maastricht University Medical Center) ;
Vij, Ravi (Washington University School of Medicine) ;
Wagner, John L. (Thomas Jefferson University) ;
William, Basem (The Ohio State University) ;
Wirk, Baldeep (Penn State Cancer Institute) ;
Yared, Jean A. (University of Maryland) ;
Spellman, Steve R. (Medical College of Wisconsin) ;
Arora, Mukta (University of Minnesota Medical Center) ;
Hamilton, Betty K. (Cleveland Clinic Taussig Cancer Institute) ;
Universitat Autònoma de Barcelona
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVHD after haploidentical hematopoietic cell transplantation (haplo-HCT) using PTCy. [...]
2020 -  10.1016/j.bbmt.2020.05.001
Biology of blood and marrow transplantation, Vol. 26 Núm. 8 (august 2020) , p. 1459-1468
|
|
|
2.
|
|
10 p, 772.3 KB |
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an international multicenter study
/
Drake, T. M. (Centre for Medical Informatics. The Usher Institute. University of Edinburgh) ;
Docherty, A. B. (Centre for Medical Informatics. The Usher Institute. University of Edinburgh) ;
Harrison, E. M. (Centre for Medical Informatics. The Usher Institute. University of Edinburgh) ;
Quint, J. K. (National Heart and Lung Institute. Imperial College) ;
Adamali, H. (Academic Respiratory Unit. University of Bristol. Southmead Hospital) ;
Agnew, Sarah (Liverpool Interstitial Lung Disease Service. Aintree site. Liverpool University Hospitals NHS Foundation Trust) ;
Babu, S. (Queen Alexandra Hospital (Portsmouth, Regne Unit)) ;
Barber, C. M. (Northern General Hospital) ;
Barratt, S. (Academic Respiratory Unit. University of Bristol. Southmead Hospital) ;
Bendstrup, Elisabeth (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Bianchi, S. (Northern General Hospital) ;
Castillo, Diego (Institut d'Investigació Biomèdica Sant Pau) ;
Chaudhuri, N. (University of Manchester) ;
Chua, F. (Royal Brompton and Harefield NHS Foundation Trust) ;
Coker, R. (Hammersmith Hospital (Londres)) ;
Chang, W. (Nottingham University Hospitals NHS Trust (Regne Unit)) ;
Crawshaw, A. (Birmingham Interstitial Lung Disease Unit. Queen Elizabeth Hospital Birmingham. University Hospitals Birmingham NHS Foundation Trust) ;
Crowley, L. E. (University of Birmingham) ;
Dosanjh, D. (Birmingham Interstitial Lung Disease Unit. Queen Elizabeth Hospital Birmingham. University Hospitals Birmingham NHS Foundation Trust) ;
Fiddler, C. A. (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Forrest, I. A. (Department of Respiratory Medicine. Royal Victoria Infirmary. Newcastle upon Tyne Hospitals NHS Foundation Trust) ;
George, P. M. (Royal Brompton and Harefield NHS Foundation Trust) ;
Gibbons, M. A. (South West Peninsula ILD Network. Royal Devon & Exeter Foundation NHS Trust) ;
Groom, K. (Hammersmith Hospital (Londres)) ;
Haney, S. (Northumbria Specialist Emergency Care Hospital. Northumbria Healthcare NHS Foundation Trust) ;
Hart, S. P. (Respiratory Research Group. Hull York Medical School. Castle Hill Hospital) ;
Heiden, E. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Henry, M. (Cork University Hospital) ;
Ho, L. P. (Oxford Interstitial Lung Disease Service. Oxford University Hospitals NHS Foundation Trust) ;
Hoyles, R. K. (Oxford Interstitial Lung Disease Service. Oxford University Hospitals NHS Foundation Trust) ;
Hutchinson, J. (King's Mill Hospital) ;
Hurley, K. (Beaumont Hospital (Dublín, Irlanda)) ;
Jones, M. (National Institute for Health Research (NIHR). Southampton Biomedical Research Centre & Clinical and Experimental Sciences. University of Southampton) ;
Jones, S. (Action for Pulmonary Fibrosis. Stuart House) ;
Kokosi, M. (Guys and St. Thomas' NHS Trust) ;
Kreuter, M. (Center for Interstitial and Rare Lung Diseases. Pneumology. Thoraxklinik. University of Heidelberg. German Center for Lung Research) ;
MacKay, L. S. (Northumbria Specialist Emergency Care Hospital. Northumbria Healthcare NHS Foundation Trust) ;
Mahendran, S. (Kingston Hospital NHS Foundation Trust) ;
Margaritopoulos, G. (ILD Unit. Manchester University Hospital NHS Foundation Trust. Wythenshawe Hospital) ;
Molina Molina, Maria (Institut d'Investigació Biomèdica de Bellvitge) ;
Molyneaux, P. L. (National Heart and Lung Institute. Imperial College) ;
O'Brien, A. (University Hospital Limerick) ;
O'Reilly, K. (Department of Respiratory Medicine. Mater Misericordiae University Hospital) ;
Packham, A. (Birmingham Interstitial Lung Disease Unit. Queen Elizabeth Hospital Birmingham. University Hospitals Birmingham NHS Foundation Trust) ;
Parfrey, H. (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Poletti, V. (Department of Diseases of the Thorax. Morgagni Hospital) ;
Porter, J. C. (UCL Respiratory. University College London. ILD Service. University College London Hospitals NHS Foundation Trust) ;
Renzoni, E. (Royal Brompton and Harefield NHS Foundation Trust) ;
Rivera-Ortega, P. (ILD Unit. Manchester University Hospital NHS Foundation Trust. Wythenshawe Hospital) ;
Russell, A. M. (Imperial Healthcare NHS Trust. St. Mary's Hospital. The Bays) ;
Saini, G. (Nottingham University Hospitals NHS Trust (Regne Unit)) ;
Spencer, L. G. (Liverpool Interstitial Lung Disease Service. Aintree site. Liverpool University Hospitals NHS Foundation Trust) ;
Stella, G. M. (Laboratory of Biochemistry and Genetics. Pneumology Unit. Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo) ;
Stone, H. (University Hospital North Midlands NHS Trust. Royal Stoke University Hospital) ;
Sturney, S. (Royal United Hospitals Bath NHS Foundation Trust) ;
Thickett, D. (University of Birmingham) ;
Thillai, M. (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Wallis, T. (National Institute for Health Research (NIHR). Southampton Biomedical Research Centre & Clinical and Experimental Sciences. University of Southampton) ;
Ward, K. (National Heart and Lung Institute. Imperial College) ;
Wells, A. U. (Royal Brompton and Harefield NHS Foundation Trust) ;
West, A. (Guys and St. Thomas' NHS Trust) ;
Wickremasinghe, M. (Imperial Healthcare NHS Trust. St. Mary's Hospital. The Bays) ;
Woodhead, F. (Institute of Lung Health. Interstitial Lung Disease Unit. Glenfield Hospital) ;
Hearson, G. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Howard, L. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Baillie, John Kenneth (Intensive Care Unit. Royal Infirmary Edinburgh) ;
Openshaw, Peter (National Heart and Lung Institute. Imperial College) ;
Semple, M. G. (Respiratory Medicine. Alder Hey Children's Hospital) ;
Stewart, I. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Jenkins, R. G. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Universitat Autònoma de Barcelona
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD hospitalized for COVID-19 versus those without ILD in a contemporaneous age-, sex-, and comorbidity-matched population. [...]
2020 - 10.1164/rccm.202007-2794OC
American Journal of Respiratory and Critical Care Medicine, Vol. 202 Núm. 12 (15 2020) , p. 1656-1665
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
